Kunming Shenghuo Pharmaceutical Group Co., LtdJoint Venture Agreement • December 21st, 2006 • China Shenghuo Pharmaceutical Holdings Inc • Pharmaceutical preparations
Unless the terms or context of this Contract provide otherwise, the following terms shall have the meaning set forth below:
AMENDMENT NO. 1 TO THE SHARE EXCHANGE AGREEMENTShare Exchange Agreement • December 21st, 2006 • China Shenghuo Pharmaceutical Holdings Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO THE SHARE EXCHANGE AGREEMENT, dated and effective as of the August 11, 2006 (this "Amendment"), is by and among SRKP 8, Inc. a Delaware corporation (the "Company"); Lan’s Int’l Medicine Investment Co., Limited, a Hong Kong corporation (the "Seller"); and Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., a company formed under the laws of the People's Republic of China ("Kunming"). The Company, the Seller and Kunming are collectively referred to herein as the "Parties". Terms not defined in this Amendment shall have such meanings as set forth in the Agreement (as defined below).
The Agreement Of Jointly Establishment of Kunming Shenghuo Pharmaceutical Science & Technology Development Co., LtdJoint Venture Agreement • December 21st, 2006 • China Shenghuo Pharmaceutical Holdings Inc • Pharmaceutical preparations
In order to exploit the resource of Yunnan Province, and to develop the high- technology Yunnan medicine, the two parts through friendly negotiations, have agreed to enter into the agreement:
LOCK-UP AGREEMENTLock-Up Agreement • December 21st, 2006 • China Shenghuo Pharmaceutical Holdings Inc • Pharmaceutical preparations
The undersigned, being a shareholder of China Shenghuo Pharmaceutical Holdings, Inc. (formerly known as SRKP 8, Inc. and referred to herein as the “Company”) and receiving his/her/its shares as an investor in the Company’s private offering that closed on August 31, 2006 (the “Private Offering”), hereby delivers this Lock-up Agreement to the Company.
